Daniel N. Swisher, Jr
2006 - Sunesis Pharmaceuticals
In 2006, Daniel N. Swisher, Jr earned a total compensation of $819.4K as Chief Executive Officer and President at Sunesis Pharmaceuticals.
Compensation breakdown
| Bonus | $115,200 |
|---|---|
| Option Awards | $353,243 |
| Salary | $349,807 |
| Other | $1,140 |
| Total | $819,390 |
Swisher received $353.2K in option awards, accounting for 43% of the total pay in 2006.
Swisher also received $115.2K in bonus, $349.8K in salary and $1.1K in other compensation.
Rankings
In 2006, Daniel N. Swisher, Jr's compensation ranked 3,528th out of 7,022 executives tracked by ExecPay. In other words, Swisher earned more than 49.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,528 out of 7,022 | 50th |
Division Manufacturing | 1,135 out of 2,413 | 53rd |
Major group Chemicals And Allied Products | 260 out of 673 | 61st |
Industry group Drugs | 167 out of 518 | 68th |
Industry Pharmaceutical Preparations | 132 out of 355 | 63rd |
Source: SEC filing on April 27, 2007.
Swisher's colleagues
We found four more compensation records of executives who worked with Daniel N. Swisher, Jr at Sunesis Pharmaceuticals in 2006.
2006
Eric Bjerkholt
Sunesis Pharmaceuticals
Chief Financial Officer
2006
Daniel Adelman
Sunesis Pharmaceuticals
Senior Vice President of Drug Discovery
2006
Daryl Winter
Sunesis Pharmaceuticals
Senior Vice President of Intellectual Property
2006
James Young
Sunesis Pharmaceuticals
Chairman
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019